Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Foundation For Angelman Syndrome Therapeutics Announces Sixth Annual Celebrity Packed "Evening With The Stars" Gala

Gala Weekend Kicks Off With a Two-Day Science Seminar Summit Detailing Advancements In Research for Treatments of Angelman Syndrome & Second Human Clinical Trial Expected to Start in Q1, 2015


News provided by

Foundation for Angelman Syndrome Therapeutics (FAST)

Nov 18, 2014, 10:00 ET

Share this article

Share toX

Share this article

Share toX

DOWNERS GROVE, Ill., Nov. 18, 2014 /PRNewswire-USNewswire/ -- The Foundation for Angelman Syndrome Therapeutics (FAST) is proud to announce its sixth annual "Evening with the Stars" Gala. The event will be held the evening of December 6th, 2014 at the Chicago Hyatt Regency Hotel. In addition to the Gala, FAST will offer a two-day science summit on Friday, December 5th and Saturday, December 6th  highlighting the latest research on treatments and a cure for Angelman Syndrome (AS), details on next human clinical trial and best practices for enhancing the lives of individuals with AS. Visit www.CureAngelman.org, to view more details on the upcoming AS clinical trial.

The Science Summit includes a seminar on an upcoming clinical trial of a small molecule compound to treat the symptoms of AS.  The seminar will be presented by Dr. Matthew During, professor of Molecular Virology, Immunology, Medical Genetics, Neuroscience and Neurosurgery at Ohio State University. Other seminars during the summit will focus on seizure treatments in AS, updates on the advances of the FAST FIRE Initiative (FAST Integrative Research Environment), which consists of four renowned researchers collaborating to fast track treatments for AS, new animal models for AS research and a literacy and communication in AS workshop.

Speakers include Dr. Douglas Nordli, Division Head at Lurie Children's Hospital of Chicago; Dr. Anne Anderson, Associate Professor at Baylor College and Medical Director at Texas Children's Hospital; Dr. Edwin Weeber, Professor at University of South Florida; Dr. David Segal, Associate Director at UC Davis Genome Center and Associate Professor at School of Medicine, M.I.N.D. Institute; Dr. Scott Dindot, Associate Professor at Texas A&M University; Dr. Jorge Piedrahita, Professor of Genomics at North Carolina State University and Dr. Caroline Musselwhite, CCC-SLP, Literacy and Assistive Technology Specialist.

The summit concludes with a star-studded, fundraising Gala. This one of a kind event kicks off with a celebrity meet and greet followed by a cocktail reception, four-course dinner, dancing and silent auction. Celebrities attending include long-time supporter, critically acclaimed actor, Golden Globe winner and fellow father of a child with AS, Colin Farrell; critically acclaimed actor Jai Courtney and actress and comedienne Retta. This magical evening provides AS parents, families and friends an opportunity to celebrate and savor in the hope that the future for their children holds.

Paula Evans, FAST Chairperson and Founder stated, "FAST is thrilled to continue our efforts in supporting the Angelman Syndrome community with funding ground breaking research and bringing the community together for a much needed and anticipated night of celebration and hope for the future. FAST is an all-volunteer organization, which allows all proceeds from the evening to go directly towards funding treatments and a cure for Angelman Syndrome. We are enormously grateful to our sponsors, supporters and amazing AS families around the globe who have all contributed to the recent and amazing advancements in AS research".

The FAST Summit & Gala is only made possible with the support of its corporate sponsors: Vivint Gives Back; unite4:good; Union Pacific; MCCI Group and Silver Lining Entertainment.

In addition to its financial support, Vivint's philanthropic arm, Vivint Gives Back, has taken its innovation to the next level by developing a security and smart home system created specifically for families of individuals with intellectual disabilities. Vivint Gives Back focuses on simplifying home life for families of individuals with intellectual disabilities. The organization embodies its cause by providing discounted installations to these families (with a target of 10,000 systems); creating custom technology to assist those with intellectual disabilities; and building unique sensory rooms in homes and schools throughout North America. The charitable efforts of Vivint Gives Back are made possible by employee donations of more than $2 million and 40,000 volunteer hours in 2014.

"Vivint Gives Back is proud to sponsor the upcoming Evening with the Stars Gala," said Holly Mero-Bench, Director of Vivint Gives Back. "Our organization is dedicated to improving the quality of life for families of individuals with intellectual disabilities, and it is an honor to further our commitment to this initiative together with FAST."

"Our mission focuses on empowering individuals and organizations who are positively impacting others, and the FAST Summit & Gala is a perfect example of how both innovation and awareness are vital in making a sustainable difference," said Anthony Melikhov, Founder of unite4:good. "We are proud to be a part of this event because it will not only highlight the plight, treatments and solutions for families currently living with Angelman Syndrome, but will also help us work towards finding a cure."

About Angelman Syndrome
Angelman Syndrome is a severe neurological disorder characterized by profound developmental delays, epilepsy, and problems with motor coordination (ataxia) and balance. Individuals with AS do not develop functional speech. The seizure disorder in individuals with Angelman Syndrome can be difficult to treat. Feeding disorders in infancy are common, and some persist throughout childhood. Sleeping difficulties are commonly noted in individuals with Angelman Syndrome. AS affects all races and both genders equally and occurs in approximately one in 10,000 to 15,000 births.  For more information about Angelman Syndrome, please visit www.CureAngelman.org.

About FAST
FAST is a Section 501(c)(3) non-profit research organization narrowly focused on funding research that holds the greatest promise of treating Angelman Syndrome. To learn more about FAST's mission and funding priorities, or to make a donation towards FAST's research program visit www.CureAngelman.org.

About Vivint
Vivint is a leading provider of smart home technology. The company delivers services through a cloud-based platform that integrates a wide range of wireless features and components to provide simple, affordable home security, energy management and home automation. Vivint's Home Automation package and Advanced Security package have received the Consumers Digest "Best Buy" rating. Dedicated to redefining the home experience with intelligent products and services, Vivint supports more than 800,000 customers throughout the U.S. and Canada. For more information, visit www.vivint.com.

About unite4:good
unite4:good is a groundbreaking new movement to inspire and empower positive, global change through acts of kindness. Through empowering action, creating new programs, and uniting both individuals and organizations in innovative ways--we will inspire positive and lasting change on a global scale. Unite4:good will encourage everyone to inspire, empower, share and love. For more information, visit www.unite4good.org.

SOURCE Foundation for Angelman Syndrome Therapeutics (FAST)

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

FAST-AFFILIATED RESEARCH PROGRAM AT UCLA IS AWARDED $5.8M TO ADVANCE GENE THERAPY FOR ANGELMAN SYNDROME

FAST-AFFILIATED RESEARCH PROGRAM AT UCLA IS AWARDED $5.8M TO ADVANCE GENE THERAPY FOR ANGELMAN SYNDROME

Dr. Roger Hollis from the University of California, Los Angeles, project scientist from the laboratory of Dr. Donald Kohn, a world leader in...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Not For Profit

Not For Profit

Corporate Social Responsibility

Corporate Social Responsibility

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.